As shown in SI Appendix, Fig. S5 K and L, treatment of tumor-bearing MYC;sgAxin1 mice with NVP-2 led to statistically significant antitumor responses and an overall extension in median survival from 18.5 d to 40 d. The gene discussed is MYC; the disease is neoplasm.